12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Kiobrina: Phase III started

Swedish Orphan began a double-blind, placebo-controlled, European Phase III trial in 70 preterm infants <32 weeks of gestational age to...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >